{"friendlyName": "Fetch Stage - Nerd", "mainSection": {"title": "Drug resistance", "sectionItems": [{"text": "Drug resistance is the reduction in effectiveness of a medication such as an antimicrobial or an antineoplastic in treating a disease or condition. The term is used in the context of resistance that pathogens or cancers have 'acquired', that is, resistance has evolved. Antimicrobial resistance and antineoplastic resistance challenge clinical care and drive research. When an organism is resistant to more than one drug, it is said to be multidrug-resistant.", "annotations": [{"surface": "Drug resistance", "start": 0, "end": 15, "uri": "https://calvoritmo.com/tfm/entity/1fd355f3-ff1e-447e-a5ea-cdcc8109ce36", "source": "b"}, {"surface": "antimicrobial", "start": 77, "end": 90, "uri": "http://dbpedia.org/resource/Antimicrobial", "source": "a"}, {"surface": "antineoplastic", "start": 97, "end": 111, "uri": "http://dbpedia.org/resource/Antineoplastic", "source": "a"}, {"surface": "disease", "start": 126, "end": 133, "uri": "http://dbpedia.org/resource/Disease", "source": "a"}, {"surface": "pathogens", "start": 199, "end": 208, "uri": "http://dbpedia.org/resource/Pathogen", "source": "a"}, {"surface": "Antimicrobial resistance", "start": 270, "end": 294, "uri": "http://dbpedia.org/resource/Antimicrobial_resistance", "source": "a"}, {"surface": "antineoplastic resistance", "start": 299, "end": 324, "uri": "http://dbpedia.org/resource/Antineoplastic_resistance", "source": "a"}, {"surface": "multidrug-resistant", "start": 439, "end": 458, "uri": "http://dbpedia.org/resource/Multiple_drug_resistance", "source": "a"}, {"surface": "Drug resistance", "start": 0, "end": 15, "uri": "http://dbpedia.org/resource/Drug_resistance", "source": "dbpedia_spotlight"}, {"surface": "antimicrobial", "start": 77, "end": 90, "uri": "http://dbpedia.org/resource/Antimicrobial", "source": "dbpedia_spotlight"}, {"surface": "antineoplastic", "start": 97, "end": 111, "uri": "http://dbpedia.org/resource/Chemotherapy", "source": "dbpedia_spotlight"}, {"surface": "Antimicrobial resistance", "start": 270, "end": 294, "uri": "http://dbpedia.org/resource/Antimicrobial_resistance", "source": "dbpedia_spotlight"}, {"surface": "antineoplastic resistance", "start": 299, "end": 324, "uri": "http://dbpedia.org/resource/Antineoplastic_resistance", "source": "dbpedia_spotlight"}, {"surface": "multidrug-resistant", "start": 439, "end": 458, "uri": "http://dbpedia.org/resource/Multiple_drug_resistance", "source": "dbpedia_spotlight"}, {"surface": "more than one", "start": 402, "end": 415, "uri": "https://calvoritmo.com/tfm/entity/250bca27-934a-479b-82fb-439606c2d31e", "source": "spacy"}]}, {"text": "The development of antibiotic resistance in particular stems from the drugs targeting only specific bacterial molecules (almost always proteins). Because the drug is so specific, any mutation in these molecules will interfere with or negate its destructive effect, resulting in antibiotic resistance. Furthermore, there is mounting concern over the abuse of antibiotics in the farming of livestock, which in the European Union alone accounts for three times the volume dispensed to humans \u2013 leading to development of super-resistant bacteria.", "annotations": [{"surface": "so", "start": 166, "end": 168, "uri": "https://calvoritmo.com/tfm/entity/59e00c96-ad40-4ff3-93ca-a8710477fef0", "source": "i"}, {"surface": "European Union", "start": 412, "end": 426, "uri": "http://dbpedia.org/resource/European_Union", "source": "a"}, {"surface": "antibiotic resistance", "start": 19, "end": 40, "uri": "http://dbpedia.org/resource/Antimicrobial_resistance", "source": "dbpedia_spotlight"}, {"surface": "mutation", "start": 183, "end": 191, "uri": "http://dbpedia.org/resource/Mutation", "source": "dbpedia_spotlight"}, {"surface": "antibiotic resistance", "start": 278, "end": 299, "uri": "http://dbpedia.org/resource/Antimicrobial_resistance", "source": "dbpedia_spotlight"}, {"surface": "farming", "start": 377, "end": 384, "uri": "http://dbpedia.org/resource/Animal_husbandry", "source": "dbpedia_spotlight"}, {"surface": "Union", "start": 421, "end": 426, "uri": "http://dbpedia.org/resource/United_States", "source": "dbpedia_spotlight"}, {"surface": "bacteria", "start": 533, "end": 541, "uri": "http://dbpedia.org/resource/Bacteria", "source": "dbpedia_spotlight"}, {"surface": "the European Union", "start": 408, "end": 426, "uri": "https://calvoritmo.com/tfm/entity/6f043358-d9a3-4947-9ead-8f09b82a2354", "source": "spacy"}, {"surface": "three", "start": 446, "end": 451, "uri": "https://calvoritmo.com/tfm/entity/8fcc8ef4-a06f-41cc-8ef6-c774f9c76a8d", "source": "spacy"}]}, {"text": "Bacteria are capable of not only altering the enzyme targeted by antibiotics, but also by the use of enzymes to modify the antibiotic itself and thus neutralize it. Examples of target-altering pathogens are Staphylococcus aureus, vancomycin-resistant enterococci and macrolide-resistant Streptococcus, while examples of antibiotic-modifying microbes are Pseudomonas aeruginosa and aminoglycoside-resistant Acinetobacter baumannii.", "annotations": [{"surface": "Staphylococcus aureus", "start": 207, "end": 228, "uri": "https://calvoritmo.com/tfm/entity/728f39e9-a898-4be3-9e87-8b291beebaa2", "source": "i"}, {"surface": "enterococci", "start": 251, "end": 262, "uri": "http://dbpedia.org/resource/Enterococci", "source": "a"}, {"surface": "Streptococcus", "start": 287, "end": 300, "uri": "https://calvoritmo.com/tfm/entity/ab39bd03-83ef-4e46-9cce-829886e9d1a0", "source": "i"}, {"surface": "Pseudomonas aeruginosa", "start": 354, "end": 376, "uri": "https://calvoritmo.com/tfm/entity/7d226d00-df49-4d71-a5d6-cccd763bcea9", "source": "i"}, {"surface": "Acinetobacter baumannii", "start": 406, "end": 429, "uri": "https://calvoritmo.com/tfm/entity/43cf8413-a551-4b19-8aad-e2f75832a944", "source": "i"}, {"surface": "Bacteria", "start": 0, "end": 8, "uri": "http://dbpedia.org/resource/Bacteria", "source": "dbpedia_spotlight"}, {"surface": "enzyme", "start": 46, "end": 52, "uri": "http://dbpedia.org/resource/Enzyme", "source": "dbpedia_spotlight"}, {"surface": "antibiotics", "start": 65, "end": 76, "uri": "http://dbpedia.org/resource/Antimicrobial_resistance", "source": "dbpedia_spotlight"}, {"surface": "antibiotic", "start": 123, "end": 133, "uri": "http://dbpedia.org/resource/Antibiotic", "source": "dbpedia_spotlight"}, {"surface": "Staphylococcus aureus", "start": 207, "end": 228, "uri": "http://dbpedia.org/resource/Staphylococcus_aureus", "source": "dbpedia_spotlight"}, {"surface": "vancomycin-resistant enterococci", "start": 230, "end": 262, "uri": "http://dbpedia.org/resource/Vancomycin-resistant_Enterococcus", "source": "dbpedia_spotlight"}, {"surface": "Streptococcus", "start": 287, "end": 300, "uri": "http://dbpedia.org/resource/Streptococcus", "source": "dbpedia_spotlight"}, {"surface": "Pseudomonas", "start": 354, "end": 365, "uri": "http://dbpedia.org/resource/Pseudomonas_aeruginosa", "source": "dbpedia_spotlight"}, {"surface": "Acinetobacter baumannii", "start": 406, "end": 429, "uri": "http://dbpedia.org/resource/Acinetobacter_baumannii", "source": "dbpedia_spotlight"}, {"surface": "Bacteria", "start": 0, "end": 8, "uri": "https://calvoritmo.com/tfm/entity/3c9798c2-9e75-43ee-b5da-645cb627aa61", "source": "spacy"}, {"surface": "Staphylococcus", "start": 207, "end": 221, "uri": "https://calvoritmo.com/tfm/entity/58bd5e08-0bd9-4488-9905-d11d84ed166a", "source": "spacy"}, {"surface": "Streptococcus", "start": 287, "end": 300, "uri": "https://calvoritmo.com/tfm/entity/84f0993e-c6f2-45f7-8a5c-b8217d21d1b6", "source": "spacy"}, {"surface": "Pseudomonas", "start": 354, "end": 365, "uri": "https://calvoritmo.com/tfm/entity/290dfb94-a25b-481c-8eaa-efbc0e6e87de", "source": "spacy"}, {"surface": "Acinetobacter", "start": 406, "end": 419, "uri": "https://calvoritmo.com/tfm/entity/1aced33b-d6ab-4e09-bbd8-e67527e57892", "source": "spacy"}]}, {"text": "In short, the lack of concerted effort by governments and the pharmaceutical industry, together with the innate capacity of microbes to develop resistance at a rate that outpaces development of new drugs, suggests that existing strategies for developing viable, long-term anti-microbial therapies are ultimately doomed to failure. Without alternative strategies, the acquisition of drug resistance by pathogenic microorganisms looms as possibly one of the most significant public health threats facing humanity in the 21st century. Some of the best alternative sources to reduce the chance of antibiotic resistance are probiotics, prebiotics, dietary fibers, enzymes, organic acids, phytogenics.", "annotations": [{"surface": "pharmaceutical industry", "start": 62, "end": 85, "uri": "http://dbpedia.org/resource/Pharmaceutical_industry", "source": "dbpedia_spotlight"}, {"surface": "drug resistance", "start": 382, "end": 397, "uri": "http://dbpedia.org/resource/Antimicrobial_resistance", "source": "dbpedia_spotlight"}, {"surface": "public health", "start": 473, "end": 486, "uri": "http://dbpedia.org/resource/Public_health", "source": "dbpedia_spotlight"}, {"surface": "antibiotic resistance", "start": 593, "end": 614, "uri": "http://dbpedia.org/resource/Antimicrobial_resistance", "source": "dbpedia_spotlight"}, {"surface": "probiotics", "start": 619, "end": 629, "uri": "http://dbpedia.org/resource/Probiotic", "source": "dbpedia_spotlight"}, {"surface": "prebiotics", "start": 631, "end": 641, "uri": "http://dbpedia.org/resource/Prebiotic_(nutrition)", "source": "dbpedia_spotlight"}, {"surface": "phytogenics", "start": 683, "end": 694, "uri": "http://dbpedia.org/resource/Phytogenics", "source": "dbpedia_spotlight"}, {"surface": "the 21st century", "start": 514, "end": 530, "uri": "https://calvoritmo.com/tfm/entity/c23cc553-4a52-45ab-ab0a-38647b338f20", "source": "spacy"}]}], "subsections": [{"title": "Mechanisms", "sectionItems": [{"text": "The four main mechanisms by which microorganisms exhibit resistance to antimicrobials are:", "annotations": [{"surface": "four", "start": 4, "end": 8, "uri": "https://calvoritmo.com/tfm/entity/c5f40efe-15dc-4f45-bfb8-247581420e6e", "source": "spacy"}]}, [{"text": "Drug inactivation or modification: e.g., enzymatic deactivation of Penicillin G in some penicillin-resistant bacteria through the production of \u03b2-lactamases.", "annotations": [{"surface": "Penicillin G", "start": 67, "end": 79, "uri": "http://dbpedia.org/resource/Penicillin", "source": "a"}, {"surface": "\u03b2-lactamases", "start": 144, "end": 156, "uri": "http://dbpedia.org/resource/Beta-lactamases", "source": "a"}, {"surface": "Penicillin G", "start": 67, "end": 79, "uri": "http://dbpedia.org/resource/Penicillin", "source": "dbpedia_spotlight"}, {"surface": "bacteria", "start": 109, "end": 117, "uri": "http://dbpedia.org/resource/Bacteria", "source": "dbpedia_spotlight"}, {"surface": "\u03b2-lactamases", "start": 144, "end": 156, "uri": "http://dbpedia.org/resource/Beta-lactamase", "source": "dbpedia_spotlight"}, {"surface": "Penicillin", "start": 67, "end": 77, "uri": "https://calvoritmo.com/tfm/entity/f076afe3-4a3b-470c-98d3-0ae8cd237ab4", "source": "spacy"}]}, {"text": "Alteration of target site: e.g., alteration of PBP \u2014 the binding target site of penicillins \u2014 in MRSA and other penicillin-resistant bacteria.", "annotations": [{"surface": "PBP", "start": 47, "end": 50, "uri": "http://dbpedia.org/resource/Penicillin-binding_protein", "source": "a"}, {"surface": "MRSA", "start": 97, "end": 101, "uri": "http://dbpedia.org/resource/Methicillin-resistant_Staphylococcus_aureus", "source": "a"}, {"surface": "penicillins", "start": 80, "end": 91, "uri": "http://dbpedia.org/resource/Penicillin", "source": "dbpedia_spotlight"}, {"surface": "MRSA", "start": 97, "end": 101, "uri": "http://dbpedia.org/resource/Methicillin-resistant_Staphylococcus_aureus", "source": "dbpedia_spotlight"}, {"surface": "bacteria", "start": 133, "end": 141, "uri": "http://dbpedia.org/resource/Bacteria", "source": "dbpedia_spotlight"}]}, {"text": "Alteration of metabolic pathway: e.g., some sulfonamide-resistant bacteria do not require para-aminobenzoic acid (PABA), an important precursor for the synthesis of folic acid and nucleic acids in bacteria inhibited by sulfonamides. Instead, like mammalian cells, they turn to utilizing preformed folic acid.", "annotations": [{"surface": "sulfonamide", "start": 44, "end": 55, "uri": "http://dbpedia.org/resource/Sulfa_drugs", "source": "a"}, {"surface": "para-aminobenzoic acid", "start": 90, "end": 112, "uri": "http://dbpedia.org/resource/Para-aminobenzoic_acid", "source": "a"}, {"surface": "folic acid", "start": 165, "end": 175, "uri": "http://dbpedia.org/resource/Folic_acid", "source": "a"}, {"surface": "nucleic acids", "start": 180, "end": 193, "uri": "http://dbpedia.org/resource/Nucleic_acids", "source": "a"}, {"surface": "metabolic pathway", "start": 14, "end": 31, "uri": "http://dbpedia.org/resource/Metabolic_pathway", "source": "dbpedia_spotlight"}, {"surface": "bacteria", "start": 66, "end": 74, "uri": "http://dbpedia.org/resource/Bacteria", "source": "dbpedia_spotlight"}, {"surface": "acid", "start": 108, "end": 112, "uri": "http://dbpedia.org/resource/Acid", "source": "dbpedia_spotlight"}, {"surface": "PABA", "start": 114, "end": 118, "uri": "http://dbpedia.org/resource/4-Aminobenzoic_acid", "source": "dbpedia_spotlight"}, {"surface": "acid", "start": 171, "end": 175, "uri": "http://dbpedia.org/resource/Acid", "source": "dbpedia_spotlight"}, {"surface": "nucleic acids", "start": 180, "end": 193, "uri": "http://dbpedia.org/resource/Nucleic_acid", "source": "dbpedia_spotlight"}, {"surface": "bacteria", "start": 197, "end": 205, "uri": "http://dbpedia.org/resource/Bacteria", "source": "dbpedia_spotlight"}, {"surface": "sulfonamides", "start": 219, "end": 231, "uri": "http://dbpedia.org/resource/Sulfonamide", "source": "dbpedia_spotlight"}, {"surface": "acid", "start": 303, "end": 307, "uri": "http://dbpedia.org/resource/Acid", "source": "dbpedia_spotlight"}, {"surface": "PABA", "start": 114, "end": 118, "uri": "https://calvoritmo.com/tfm/entity/fab0b562-255f-4028-8279-f0c042fa02eb", "source": "spacy"}]}, {"text": "Reduced drug accumulation: by decreasing drug permeability and/or increasing active efflux (pumping out) of the drugs across the cell surface.", "annotations": [{"surface": "permeability", "start": 46, "end": 58, "uri": "http://dbpedia.org/resource/Semipermeable_membrane", "source": "a"}, {"surface": "efflux", "start": 84, "end": 90, "uri": "http://dbpedia.org/resource/Efflux_(microbiology)", "source": "a"}, {"surface": "permeability", "start": 46, "end": 58, "uri": "http://dbpedia.org/resource/Semipermeable_membrane", "source": "dbpedia_spotlight"}]}]], "subsections": []}]}}